Surgical Treatment for Trapeziometacarpal Osteoarthritis Eaton & Glickel Stage 4

NCT ID: NCT02204995

Last Updated: 2016-09-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

62 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-09-30

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Trapeziometacarpal osteoarthritis is a common cause of pain and loss of hand function in postmenopausal women. Many surgical treatments have been described and recent literature has show that the relatively simple trapeziectomy gives equal results and less complications, when compared to other techniques such as ligament reconstructions and interpositions. These studies have been conducted predominantly in patients with stage 2 or 3 osteoarthritis. Stage 4 osteoarthritis is characterized by more cartilage and soft-tissue damage, which increases the chance for collapse of the first metacarpal bone and associated problems.

The investigators' hypothesis is that an LRTI can be of additional value in patients with stage 4 osteoarthritis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Trapeziometacarpal Osteoarthritis Thumb Carpometacarpal Osteoarthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Trapeziectomy with LRTI

Trapeziectomy with Ligament Reconstruction and Tendon Interposition

Group Type ACTIVE_COMPARATOR

Trapeziectomy with LRTI

Intervention Type PROCEDURE

Trapeziectomy with Ligament Reconstruction and Tendon Interposition

Trapeziectomy

Trapeziectomy

Group Type ACTIVE_COMPARATOR

Trapeziectomy

Intervention Type PROCEDURE

Trapeziectomy

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Trapeziectomy with LRTI

Trapeziectomy with Ligament Reconstruction and Tendon Interposition

Intervention Type PROCEDURE

Trapeziectomy

Trapeziectomy

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women
* 40 years of age or more
* Symptomatic trapeziometacarpal osteoarthritis
* Eaton \& Glickel stage 4

Exclusion Criteria

* An operation for trapeziometacarpal osteoarthritis on the same hand in the past.
* Participation in randomized clinical trial for trapeziometacarpal osteoarthritis with contralateral hand.
* Secondary trapeziometacarpal osteoarthritis as result of trauma, rheumatoid arthritis, systemic lupus or gout.
* Symptomatic carpal tunnel syndrome in same hand.
* Symptomatic Quervain's tenosynovitis in same hand.
* Neurological or other disorders of the affected side that can influence postoperative rehabilitation.
* Insufficient knowledge of Dutch language.
Minimum Eligible Age

40 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Isala

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ramon de Wildt

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jeroen H. van Uchelen, MD

Role: STUDY_CHAIR

Isala

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Isala Hospital

Zwolle, Overijssel, Netherlands

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Netherlands

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Ramon P. de Wildt, MD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Ramon P. de Wildt, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NL48197.075.14

Identifier Type: REGISTRY

Identifier Source: secondary_id

NL48197.075.14

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

CMC I Stability Intraoperative
NCT03687775 COMPLETED